Home
Contact us
Site map
Québec.ca
FAQ
Français
Advanced search
Consolidated Statutes and Regulations
Consolidated Statutes
Consolidated Regulations
Annual Statutes and Regulations
Annual Statutes
Annual Regulations
Additional information
Québec Official Publisher
What’s new?
Information note
Policy of the Minister of Justice
Laws: Amendments
Laws: Provisions not in force
Laws: Provisions brought into force
Annual Statutes: PDF versions since 1996
Regulations: Amendments
Annual Regulations: PDF versions since 1996
Court Decisions
s-0.1, r. 12
- Regulation respecting drugs that a midwife may prescribe or administer in the practice of midwifery
Table of contents
Occurrences
0
Full text
Replaced on 1 March 2021
This document has official status.
chapter
S-0.1, r. 12
Regulation respecting drugs that a midwife may prescribe or administer in the practice of midwifery
MIDWIVES — DRUGS
Midwives Act
(chapter S-0.1, s. 9, 1st par.)
.
S-0.1
09
September
01
1
2012
Replaced, O.C. 1376-2020, 2021 G.O. 2, 86; eff. 2021-03-01; see
chapter S-0.1, r. 12.1
.
1
.
The drugs that a midwife may prescribe or administer are
(
1
)
the drugs for the mother listed in Schedule I, on the conditions, if applicable, determined in the Schedule; and
(
2
)
the drugs for the child listed in Schedule II, on the conditions determined in the Schedule.
O.C. 967-2008, s. 1
.
2
.
(Omitted).
O.C. 967-2008, s. 2
.
SCHEDULE I
(
s. 1
)
DRUGS THAT A MIDWIFE MAY PRESCRIBE OR ADMINISTER TO THE MOTHER
Substances Specifications and conditions
Acetaminophen For use during the prenatal and postpartum
period
Acetaminophen and codeine Pharmaceutical form containing 325 mg or less
(in combination) of acetaminophen and 30 mg or less of codeine
per tablet
Limited quantity for a 2-day period
Acetaminophen, caffeine and Pharmaceutical form containing 300 mg or less
codeine (in combination) of acetaminophen, 15 mg or less of caffeine
and 8 mg or less of codeine per tablet
Limited quantity for a 2-day period
Alginic acid
Aluminum hydroxide and magnesium hydroxide
Ampicillin Pharmaceutical form for parenteral
administration in prophylaxis during the
prolonged rupture of membranes in asymptomatic
women or in prophylaxis in respect of
beta-hemolytic streptococcus
Betamethasone, clotrimazole and Pharmaceutical form for topical administration
mupirocin (in combination) in a concentration of 0.1% betamethasone, 10%
clotrimazole and 2% mupirocin for the
treatment of fungal infections on nipples of
breastfeeding women
Betamethasone, miconazole and Pharmaceutical form for topical administration
mupirocin (in combination) in a concentration of 0.1% betamethasone, 2%
miconazole and 2% mupirocin for the treatment
of fungal infections on nipples of
breastfeeding women
Calcium carbonate
Calcium gluconate Pharmaceutical form for parenteral
administration in a concentration of 10% as
antidote for magnesium sulphate while awaiting
transfer of clinical responsibility to a
physician
Carboprost tromethamine Pharmaceutical form for parenteral
administration in a concentration of 0.25 mg
in prophylaxis or if hemorrhage during the
immediate postpartum period and synthetic
oxytocin is ineffective
Clindamycin Pharmaceutical form for parenteral
administration in prophylaxis in respect of
beta-hemolytic streptococcus, if allergy to
penicillin G
Clotrimazole Pharmaceutical forms for topical and vaginal
administration in a concentration of 1%
Dextrose Pharmaceutical form for parenteral infusion
administration in a concentration of 5%
Or
Pharmaceutical form for oral administration
for a glucose tolerance test
Dextrose and sodium chloride Pharmaceutical form for parenteral infusion
(in combination) administration in a concentration of 5%
dextrose and 0.45% sodium chloride
Diazepam Pharmaceutical form for rectal administration
for the treatment of seizures, if magnesium
sulphate is ineffective
Diphenhydramine hydrochloride Pharmaceutical form for parenteral
administration for the treatment of allergic
reactions, with or without anaphylactic
reaction, with no increased body temperature
or systemic illness
Docusate calcium Pharmaceutical form for oral administration
during the prenatal and postpartum period
Docusate sodium Pharmaceutical form for oral administration
during the prenatal and postpartum period
Doxylamine succinate and Pharmaceutical form containing 10 mg of
pyridoxine hydrochloride doxylamine succinate and 10 mg of pyridoxine
(in combination) hydrochloride per tablet
Epinephrine Presented in the form of auto-injector or
ampoule in a concentration of 1 mg/ml for the
emergency treatment of anaphylactic reactions
Ergonovine maleate Pharmaceutical form for parenteral
administration in prophylaxis or if hemorrhage
during the immediate postpartum period and
synthetic oxytocin is ineffective
Erythromycin Pharmaceutical form for parenteral
administration in prophylaxis in respect of
beta-hemolytic streptococcus, if allergy to
penicillin G and resistance to clindamycin
Ferrous fumarate Pharmaceutical form for oral administration,
if intolerance to ferrous sulphate
Ferrous gluconate Pharmaceutical form for oral administration,
if intolerance to ferrous sulphate or ferrous
fumarate
Ferrous sulphate Pharmaceutical form for oral administration
Folic acid Pharmaceutical form for oral administration
during the prenatal period
Glycerin Pharmaceutical form for rectal administration
Hamamelis and glycerin Pharmaceutical form for topical administration
(in combination) in a concentration of 50% hamamelis
Human immunoglobulin Pharmaceutical form for parenteral
administration during the prenatal and
postpartum period
Hydrocortisone and zinc Pharmaceutical form for rectal administration
sulphate (in combination) in a concentration of 0.5% hydrocortisone and
0.5% zinc sulphate
Ibuprofen For use during the postpartum period
Lidocaine Pharmaceutical form for topical administration
in a concentration of 4% for action on vaginal
mucus while repairing minor lacerations
Or
Pharmaceutical form for parenteral
administration in a concentration of 1%
Lorazepam Pharmaceutical forms for oral and sublingual
administration for manual removal of the
placenta, if hemorrhage
Magnesium sulphate Pharmaceutical form for parenteral
administration for the treatment of seizures
Miconazole Pharmaceutical forms for topical and vaginal
administration during the prenatal period in a
concentration of 2%
Misoprostol Pharmaceutical forms for oral or rectal
administration if hemorrhage during the
immediate postpartum period or synthetic
oxytocin is ineffective or unavailable
MMR vaccine Pharmaceutical form for parenteral
administration during the postpartum period
Morphine Pharmaceutical form for parenteral
administration during the neonatal period in
prolonged latency in primiparous women and
during the postpartum period
Multivitamins and minerals
Nitroglycerin Pharmaceutical form for sublingual spray
administration if excessive uterine activity
with a non-reassuring fetal heart rate or
prolapsed cord
Penicillin G Pharmaceutical form for parenteral
administration in prophylaxis in respect of
beta-hemolytic streptococcus
Psyllium (mucilage) Pharmaceutical form for oral administration
during the prenatal and postpartum period
Ringer’s lactate Pharmaceutical form for parenteral infusion
administration for fluid replacement if
substantial postpartum loss of blood or if
hemorrhage
Sodium chloride Pharmaceutical form for parenteral infusion
administration in a concentration of 0.9% for
fluid replacement if substantial postpartum
loss of blood, if hemorrhage or for dilution
Sodium citrate/sodium lauryl Pharmaceutical form for rectal administration
sulfate
Synthetic oxytocin Pharmaceutical form for parenteral
administration in prophylaxis or if hemorrhage
during the immediate postpartum period
Terconazole Pharmaceutical forms for topical and vaginal
administration during the prenatal period in a
concentration of 0.4%, if clotrimazole and
miconazole are ineffective
Vitamin B6 Pharmaceutical form for oral administration
for the treatment of nausea during the
prenatal period
Vitamin B12 For use during the prenatal period
Vitamin D and calcium Pharmaceutical form for oral administration in
(in combination) prophylaxis
O.C. 967-2008, Sch. I
.
SCHEDULE II
(
s. 1
)
DRUGS THAT A MIDWIFE MAY PRESCRIBE OR ADMINISTER TO THE CHILD
Substances Specifications and conditions
Ampicillin Pharmaceutical form for parenteral
administration in newborns having an emergency
condition and after a medical consultation
Epinephrine Pharmaceutical forms for parenteral and
endotracheal administration in a concentration
of 0.1 mg/ml during neonatal resuscitation
Erythromycin Pharmaceutical form for ophthalmic
administration in a concentration of 0.5% in
prophylaxis in newborns
Gentamicin Pharmaceutical form for parenteral
administration in newborns having an emergency
condition and after a medical consultation
Gentian violet Pharmaceutical form for topical
administration, in a water solution, in a
concentration of 1% or less
Hepatitis B immune globulin Pharmaceutical form for parenteral
administration
Hepatitis B vaccine Pharmaceutical form for parenteral
administration
Naloxone hydrochloride Pharmaceutical form for parenteral
administration in a concentration of 0.4 mg/ml
in newborns having an emergency condition
Nystatin Pharmaceutical form for oral administration,
presented in the form of a suspension for the
treatment of non-recurrent, non- resistant
oral mycosis
Penicillin G Pharmaceutical form for parenteral
administration in newborns having an emergency
condition and after a medical consultation
Sodium chloride Pharmaceutical form for parenteral infusion
administration in a concentration of 0.9% in
newborns having an emergency condition or for
dilution
Vitamin D Pharmaceutical form for oral administration in
breastfed infants
Vitamin K1 Pharmaceutical form for parenteral and
oral administration
O.C. 967-2008, Sch. II
.
REFERENCES
O.C. 967-2008, 2008 G.O. 2, 5005
Copy
Select this element
Select parent element
Unselect all
Copy to Drafting
Copy to LAW
Copy to Clipboard
×
To copy : Ctrl+C
0
Contact us
Site map
Québec.ca
Accessibility
Privacy policy
© Gouvernement du Québec
Selections
×
Show
Selections in current document
All selections in the collection
Selected elements
Delete all selections
Show selections
Cyberlex
×
Version 2.2.0.3